These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3540497)

  • 41. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 43. DDS-resistant leprosy.
    Neelan PN; Reddy BN
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):115-8. PubMed ID: 3889186
    [No Abstract]   [Full Text] [Related]  

  • 44. The susceptibility testing of 13 strains of Mycobacterium leprae to rifampicin and the determination of minimal effective dosage.
    Wang HY; Li WZ; Ye GY; Yu LC; Shi MQ
    Lepr Rev; 1991 Sep; 62(3):276-9. PubMed ID: 1795586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress in leprosy research.
    WHO Chron; 1966 Mar; 20(3):98-100. PubMed ID: 5325357
    [No Abstract]   [Full Text] [Related]  

  • 46. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616
    [No Abstract]   [Full Text] [Related]  

  • 48. [Drug sensitivity test of M. leprae using liquid media (author's transl)].
    Murohashi T; Yoshida K
    Repura; 1976; 45(1):1-8. PubMed ID: 799737
    [No Abstract]   [Full Text] [Related]  

  • 49. Rapid detection of resistance to rifampicin in Mycobacterium leprae.
    Roche PW; Shrestha N; Thomas A; Honore N; Cole ST
    Lepr Rev; 2000 Dec; 71 Suppl():S96-7; discussion S97-9. PubMed ID: 11201897
    [No Abstract]   [Full Text] [Related]  

  • 50. The problem of dapsone-resistant leprosy.
    Pearson JM
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
    [No Abstract]   [Full Text] [Related]  

  • 51. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 53. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

  • 54. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

  • 55. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 57. A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
    Honoré N; Perrani E; Telenti A; Grosset J; Cole ST
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):600-4. PubMed ID: 8151192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

  • 59. [Dapsone resistance in West Africa].
    Pattyn SR; Baquillon G; Ferracci C; Saint-André P; Cap JA; Vandroogenbroeck J
    Acta Leprol; 1979; (76-77):321-4. PubMed ID: 121854
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug sensitivity testing of M. leprae.
    Grosset J; Levy L; Rees RJ; Shepard CC
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):118-21. PubMed ID: 3889187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.